HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of an inhaled antihistamine (clemastine) as a bronchodilator and as a maintenance treatment in asthma.

Abstract
Although intravenous chlorpheniramine can cause bronchodilatation, oral and parenteral antihistamines have not proved useful in treating asthma. Inhaled antihistamines may cause throat irritation, but a recent study of the antihistamine, clemastine, showed it to be an effective bronchodilator without irritant effects. We have extended these studies to determine the site of action of inhaled clemastine and to assess its potential usefulness both as a bronchodilator and as a maintenance treatment. Eleven stable asthmatic patients received inhaled clemastine and placebo and the effect was assessed by serial maximum expiratory flow volume (MEFV) curves breathing air and a helium/oxygen (He/O2) mixture. There was no significant improvement in peak flow rates during air breathing after clemastine and no significant difference between the responses to drug and placebo. Minor but significant changes were seen in some flow measurements on the downslope of the MEFV curve during air and He/O2 breathing, and these are tentatively ascribed to a dilating effect of clemastine on peripheral airways where flow is laminar. Subsequent administration of inhaled isoprenaline showed the patients to be still capable of significant bronchodilatation. The addition of clemastine, from a pressurised aerosol, to the patients' therapeutic regimen for two weeks was no more effective than placebo in controlling airflow obstruction, and did not reduce the need for standard bronchodilators. In our patients clemastine was not a clinically useful bronchodilator either acutely or as a maintenance treatment for asthma.
AuthorsM R Partridge, K B Saunders
JournalThorax (Thorax) Vol. 34 Issue 6 Pg. 771-6 (Dec 1979) ISSN: 0040-6376 [Print] England
PMID396687 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Aerosols
  • Bronchodilator Agents
  • Placebos
  • Pyrrolidines
  • Clemastine
Topics
  • Adult
  • Aerosols
  • Aged
  • Asthma (drug therapy)
  • Bronchodilator Agents
  • Clemastine (administration & dosage, therapeutic use)
  • Clinical Trials as Topic
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Maximal Expiratory Flow Rate
  • Middle Aged
  • Placebos
  • Pyrrolidines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: